🔖
Bu Makaleye Atıf Yap
SAYINER, A. (2020). Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal, Cilt: 21 - Sayı: 4, 283–284. https://ajindex.com/articles/418108
Dergiler / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 4
Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base
- Sayfa
- 283–284
- DOI
- —
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗Kaynakça (5)
- World Health Organization. COVID-19 Situation Dashboard. Available from: URL. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd 2
- TC Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. Available from: URL:
- World Health Organization. COVID-19 Situation Report. Available from: URL:
- T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COVID-19 (SARS-CoV2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması) 25 Mart 2020. www.hsgm.saglik.gov.tr 5. Agrawal S, Gupta N, Goel AD. Evidence based treatment of SARS-CoV2 - A narrative review. Turk Thorac J 2020;21(3):221-2. [Crossref] 6. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020
- Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020. [Crossref] 8. Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis 2020. [Crossref]